Nucletron highlights tools for advanced imaging and treatment planning

Nucletron B.V. showed two of its tools in radiation treatment the Oncentra ConeBeam and Oncentra MasterPlan at the American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Denver, Colo., in mid-October.
   
Through the Oncentra ConeBeam, the acquisition and reconstructing of CT images from 3D isotropic data is possible. The system can be used in conjunction with the Simulix Evolution simulator to create a radiation therapy imaging tool that can perform conventional and CT assisted simulation on the same platform, giving clinicians access to both techniques. The Oncentra ConeBeam has just recently received 510(k) clearance from the FDA, Nucletron said.

The Greater Baltimore Medical Center in Maryland is the first site in the U.S. to install the Oncentra ConeBeam clinically.
   
Also highlighted at the conference was the company's Oncentra MasterPlan which is designed for location-independent radiation therapy treatment planning.

The Plan Analysis tool within MasterPlan allow clinics to simultaneously review treatment plans amongst several users and thus enables specialized skills to be concentrated independent of location. Also, modifications can be made to target volumes and beams from remote locations, the company said.
   
Additional features of the MasterPlan include electronic medical record (EMR) capabilities; DICOM RT archive compatability; IMRT optimization; anatomy modification capabilities; distribution planning; and a PC-based, vendor-neutral architecture.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.